We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

More & More?

27 April 2011 By Robert Cyran

The U.S. health giant’s $21.3 bln purchase of Synthes is its largest ever. A big deal seemed a way for J&J to deploy its $28 bln of cash, largely trapped overseas. But it is paying mostly in stock. Despite problems with its current businesses, J&J may have further deals in mind.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)